These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4002225)

  • 41. Effect of ascorbic acid on brain amphetamine concentrations in the rat.
    Kiely ME; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):287-90. PubMed ID: 3628833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats.
    Baker LE; Makhay MM
    Pharmacol Biochem Behav; 1996 Feb; 53(2):455-61. PubMed ID: 8808158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible relationships between changes in body weight set-point and stress metabolism after treating rats chronically with D-fenfluramine. Effects of feeding rats acutely with fructose on the metabolism of corticosterone, glucose, fatty acids, glycerol and triacylglycerol.
    Brindley DN; Saxton J; Shahidullah H; Armstrong M
    Biochem Pharmacol; 1985 Apr; 34(8):1265-71. PubMed ID: 3994746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amphetamine cumulation and tolerance development: concurrent and opposing phenomena.
    Sparber SB; Fossom LH
    Pharmacol Biochem Behav; 1984 Mar; 20(3):415-24. PubMed ID: 6709676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of anorectic drugs in rats trained to discriminate between satiation and deprivation.
    Schechter MD
    Life Sci; 1990; 47(1):17-24. PubMed ID: 2388514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative study of the anorectic activity of phenindamine d-amphetamine and fenfluramine in different species.
    Abdallah A; White HD
    Arch Int Pharmacodyn Ther; 1970 Dec; 188(2):271-83. PubMed ID: 5523473
    [No Abstract]   [Full Text] [Related]  

  • 47. Single- and multiple-dose kinetics of d-fenfluramine in rats given anorectic and toxic doses.
    Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
    Xenobiotica; 1992 Feb; 22(2):217-26. PubMed ID: 1632111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the mechanisms of tolerance to the anorectic effect of salbutamol in rats.
    Bendotti C; Borsini F; Samanin R
    Eur J Pharmacol; 1983 Sep; 92(3-4):237-42. PubMed ID: 6138263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methamphetamine, fenfluramine and their N-dealkylated metabolites: effect on monoamine concentrations in rat tissues.
    Morgan CD; Cattabeni F; Costa E
    J Pharmacol Exp Ther; 1972 Jan; 180(1):127-35. PubMed ID: 5010410
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of viloxazine on drug-induced inhibition of food intake in the rat.
    Pleece SA; Kirby MJ; Redfern PH
    J Pharm Pharmacol; 1980 Aug; 32(8):558-60. PubMed ID: 6106693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs.
    Mennini T; Bizzi A; Caccia S; Codegoni A; Fracasso C; Frittoli E; Guiso G; Padura IM; Taddei C; Uslenghi A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):483-90. PubMed ID: 1881458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperthermia induced by amphetamine, p-chloroamphetamine and fenfluramine in the rat-1.
    Frey H-H
    Pharmacology; 1975; 13(2):163-76. PubMed ID: 124876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Does fenfluramine mean a real advance in the treatment of obesity?].
    Chruściel M; Chruściel TL
    Postepy Hig Med Dosw; 1973; 27(3):365-90. PubMed ID: 4198497
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.
    Fletcher PJ
    Psychopharmacology (Berl); 1995 Mar; 118(2):155-63. PubMed ID: 7617802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolerance does not develop to the suppressant effects of (-)-norpseudoephedrine on ingestive behavior in the rat.
    Nencini P; Fraioli S; Perrella D
    Pharmacol Biochem Behav; 1996 Feb; 53(2):297-301. PubMed ID: 8808135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary modulation of the anorectic potency of amphetamine.
    Marks-Kaufman R; Kanarek RB
    Pharmacol Biochem Behav; 1990 Feb; 35(2):301-6. PubMed ID: 2320637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclo(His-Pro) potentiates the reduction of food intake induced by amphetamine, fenfluramine, or serotonin.
    Kow LM; Pfaff DW
    Pharmacol Biochem Behav; 1991 Feb; 38(2):365-9. PubMed ID: 2057504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A dose-response study of anorectic drug effects on food intake, self-stimulation, and stimulation-escape.
    Kornblith CL; Hoebel BG
    Pharmacol Biochem Behav; 1976 Aug; 5(2):215-8. PubMed ID: 996053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feeding pattern studies suggest that d-fenfluramine and sertraline specifically enhance the state of satiety in rats.
    Grignaschi G; Neill JC; Petrini A; Garattini S; Samanin R
    Eur J Pharmacol; 1992 Feb; 211(2):137-42. PubMed ID: 1612106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic fenfluramine treatment: effects on body weight, food intake and energy expenditure.
    Stallone DD; Levitsky DA
    Int J Obes Relat Metab Disord; 1994 Oct; 18(10):679-85. PubMed ID: 7866463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.